Visceral leishmaniasis as an AIDS defining condition: towards consistency across WHO guidelines

. 2014 Jul 17;8(7):e2916.

doi: 10.1371/journal.pntd.0002916. eCollection 2014 Jul.

Affiliations

Johan van Griensven et al. PLoS Negl Trop Dis. 2014.

. 2014 Jul 17;8(7):e2916.

doi: 10.1371/journal.pntd.0002916. eCollection 2014 Jul.

¹ Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
² Public Health Department, Médecins Sans Frontières, Amsterdam, The Netherlands.
³ Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Internal Medicine, University of Gondar, Gondar, Ethiopia.

No abstract available

Conflict of interest statement

The authors have declared that no competing interests exist.

1. Alvar J, Aparicio P, Aseffa A, Den Boer M, Canavate C, et al. (2008) The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21: 334–359. - PMC - PubMed
1. Desjeux P, Alvar J (2003) Leishmania/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol 97 Suppl 1: 3–15. - PubMed
1. Lopez-Velez R, Casado JL, Pintado V (2001) Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART). Clin Microbiol Infect 7: 394–395. - PubMed
1. Ritmeijer K, ter Horst R, Chane S, Aderie EM, Piening T, et al. (2011) Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence. Clin Infect Dis 53: e152–158. - PubMed
1. Hurissa Z, Gebre-Silassie S, Hailu W, Tefera T, Lalloo DG, et al. (2010) Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia. Trop Med Int Health 15: 848–855. - PubMed